{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:54:28Z","timestamp":1768290868600,"version":"3.49.0"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T00:00:00Z","timestamp":1459123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0152007","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T17:36:53Z","timestamp":1459186613000},"page":"e0152007","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease"],"prefix":"10.1371","volume":"11","author":[{"given":"Elena-Raluca","family":"Nicoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Al Eisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine V. M.","family":"Cluzeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Wassif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn R.","family":"Burkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"Cologna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody J.","family":"Peer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan M.","family":"Sissung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin-Daniel","family":"Uscatu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Vite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"M Vanier","year":"2010","journal-title":"Orphanet journal of rare diseases"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1022575511354","article-title":"Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature","volume":"24","author":"MT Vanier","year":"1999","journal-title":"Neurochem Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-8-12","article-title":"Disease and patient characteristics in NP-C patients: findings from an international disease registry","volume":"8","author":"MC Patterson","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","article-title":"High incidence of unrecognized visceral\/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets","author":"CA Wassif","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.nbd.2004.05.002","article-title":"Treatment with miglustat reverses the lipid-trafficking defect in Niemann\u2013Pick disease type C","volume":"16","author":"RH Lachmann","year":"2004","journal-title":"Neurobiology of disease"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"MC Patterson","year":"2007","journal-title":"Lancet neurology"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","article-title":"Miglustat in adult and juvenile patients with Niemann\u2013Pick disease type C: Long-term data from a clinical trial","volume":"99","author":"JE Wraith","year":"2010","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0883073809344222","article-title":"Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C","volume":"25","author":"MC Patterson","year":"2010","journal-title":"Journal of Child Neurology"},{"issue":"16","key":"ref9","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/hmg\/dds193","article-title":"Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1","volume":"21","author":"CV Cluzeau","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"5323","key":"ref10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"SK Loftus","year":"1997","journal-title":"Science"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nm.1876","article-title":"Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium","volume":"14","author":"E Lloyd-Evans","year":"2008","journal-title":"Nat Med"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2009.07.010","article-title":"Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1","volume":"36","author":"D Smith","year":"2009","journal-title":"Neurobiology of disease"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1096\/fj.07-102715","article-title":"Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease","volume":"22","author":"AR Alvarez","year":"2008","journal-title":"The FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"52","key":"ref14","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1523\/JNEUROSCI.4823-07.2007","article-title":"Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse","volume":"27","author":"JJ Repa","year":"2007","journal-title":"Journal of Neuroscience"},{"issue":"37","key":"ref15","doi-asserted-by":"crossref","first-page":"13807","DOI":"10.1073\/pnas.0606218103","article-title":"Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease","volume":"103","author":"SJ Langmade","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/1568026613666131127160118","article-title":"Collaborative development of 2-hydroxypropyl-beta-cyclodextrin for the treatment of Niemann-Pick type C1 disease","volume":"14","author":"EA Ottinger","year":"2014","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","article-title":"Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update","volume":"106","author":"MC Patterson","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","article-title":"Niemann-Pick disease type C","volume":"64","author":"MT Vanier","year":"2003","journal-title":"Clinical Genetics"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(05)81695-6","article-title":"Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease","volume":"123","author":"DA Kelly","year":"1993","journal-title":"The Journal of pediatrics"},{"key":"ref20","article-title":"Primary biliary cirrhosis","author":"EJ Carey","year":"2015","journal-title":"Lancet"},{"issue":"9204","key":"ref21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(05)72401-6","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"355","author":"KD Lindor","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"C Corpechot","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1005395709826","article-title":"Niemann-Pick disease type C and defective peroxisomal beta-oxidation of branched-chain substrates","volume":"21","author":"JS Sequeira","year":"1998","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"ref24","first-page":"535","article-title":"Chemopreventive efficacy and pharmacokinetics of curcumin in the min\/+ mouse, a model of familial adenomatous polyposis","volume":"11","author":"S Perkins","year":"2002","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"21","key":"ref25","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"GP Lim","year":"2001","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"issue":"1\u20132","key":"ref26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tox.2007.03.007","article-title":"Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products","volume":"235","author":"R Appiah-Opong","year":"2007","journal-title":"Toxicology"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3835(92)90275-Z","article-title":"Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A\/J mice","volume":"66","author":"G Jalbert","year":"1992","journal-title":"Cancer Letters"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.biochi.2012.06.016","article-title":"On the formation and possible biological role of 25-hydroxycholesterol","volume":"95","author":"U Diczfalusy","year":"2013","journal-title":"Biochimie"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/138920011795016890","article-title":"Regulation of hepatic cytochromes p450 by lipids and cholesterol","volume":"12","author":"M Hafner","year":"2011","journal-title":"Curr Drug Metab"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.abb.2004.09.019","article-title":"Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism","volume":"433","author":"JJ Eloranta","year":"2005","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-2275(20)32210-0","article-title":"Identification of unusual 7-oxygenated bile acid sulfates in a patient with Niemann-Pick disease, type C","volume":"42","author":"G Alvelius","year":"2001","journal-title":"J Lipid Res"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.steroids.2013.05.017","article-title":"LC\/ESI-MS\/MS analysis of urinary 3beta-sulfooxy-7beta-N-acetylglucosaminyl-5-cholen-24-oic acid and its amides: new biomarkers for the detection of Niemann-Pick type C disease","volume":"78","author":"M Maekawa","year":"2013","journal-title":"Steroids"},{"key":"ref33","article-title":"Focused metabolomics using liquid chromatography\/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann-Pick disease type C and 3beta-hydroxysteroid dehydrogenase deficiency","author":"M Maekawa","year":"2015","journal-title":"Ann Clin Biochem"},{"issue":"56","key":"ref34","doi-asserted-by":"crossref","first-page":"56ra81","DOI":"10.1126\/scitranslmed.3001417","article-title":"Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease","volume":"2","author":"FD Porter","year":"2010","journal-title":"Science translational medicine"},{"issue":"16","key":"ref35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0960-9822(01)00396-7","article-title":"Critical role for glycosphingolipids in Niemann-Pick disease type C","volume":"11","author":"M Zervas","year":"2001","journal-title":"Curr Biol"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/dmd.105.004721","article-title":"Midazolam and cyclosporin a metabolism in transgenic mice with liver-specific expression of human CYP3A4","volume":"33","author":"AE van Herwaarden","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1111\/j.1476-5381.2012.01933.x","article-title":"CYP3A-dependent drug metabolism is reduced in bacterial inflammation in mice","volume":"166","author":"AS Gandhi","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0026-895X(25)09118-7","article-title":"Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4","volume":"36","author":"T Kronbach","year":"1989","journal-title":"Mol Pharmacol"},{"issue":"Suppl 1","key":"ref39","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1111\/j.1365-2125.1983.tb02270.x","article-title":"Pharmacokinetics and bioavailability of midazolam in man","volume":"16","author":"P Heizmann","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1124\/dmd.110.035295","article-title":"Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7","volume":"38","author":"KA Seo","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"33","key":"ref41","doi-asserted-by":"crossref","first-page":"29561","DOI":"10.1074\/jbc.M202739200","article-title":"Cholesterol and bile acids regulate xenosensor signaling in drug-mediated induction of cytochromes P450","volume":"277","author":"C Handschin","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1194\/jlr.M007211","article-title":"Recovery from liver disease in a Niemann-Pick type C mouse model","volume":"51","author":"NL Sayre","year":"2010","journal-title":"Journal of Lipid Research"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1665-2681(19)32103-9","article-title":"Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial","volume":"3","author":"N Mendez-Sanchez","year":"2004","journal-title":"Ann Hepatol"},{"issue":"13","key":"ref44","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/mds.22744","article-title":"Spiral analysis in Niemann-Pick disease type C","volume":"24","author":"AW Hsu","year":"2009","journal-title":"Mov Disord"},{"issue":"4","key":"ref45","first-page":"472","article-title":"Miglustat. Oxford GlycoSciences\/Actelion","volume":"4","author":"RH Lachmann","year":"2003","journal-title":"Current opinion in investigational drugs"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"M Martignoni","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(94)90363-8","article-title":"Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver","volume":"48","author":"MD Burke","year":"1994","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-2952(93)90504-P","article-title":"Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse","volume":"46","author":"PV Nerurkar","year":"1993","journal-title":"Biochemical pharmacology"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants","volume":"14","author":"DR Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Sex differences in the expression of hepatic drug metabolizing enzymes","volume":"76","author":"DJ Waxman","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1073\/pnas.96.1.266","article-title":"Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta","volume":"96","author":"BA Janowski","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6602","key":"ref52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"BA Janowski","year":"1996","journal-title":"Nature"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1021\/jm0004749","article-title":"Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha","volume":"44","author":"TA Spencer","year":"2001","journal-title":"J Med Chem"},{"issue":"5548","key":"ref54","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: opening the X-files","volume":"294","author":"A Chawla","year":"2001","journal-title":"Science"},{"issue":"4 Pt 1","key":"ref55","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/jhep.2002.35617","article-title":"Relevance of Niemann-Pick type C1 protein expression in controlling plasma cholesterol and biliary lipid secretion in mice","volume":"36","author":"L Amigo","year":"2002","journal-title":"Hepatology"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/jnen\/59.12.1106","article-title":"Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased","volume":"59","author":"C Xie","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2133\/dmpk.23.14","article-title":"Interplay of pregnane X receptor with other nuclear receptors on gene regulation","volume":"23","author":"YP Lim","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"UM Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"12","key":"ref59","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1074\/jbc.M412898200","article-title":"Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function","volume":"280","author":"W Yu","year":"2005","journal-title":"J Biol Chem"},{"issue":"23","key":"ref60","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1074\/jbc.M114.559914","article-title":"Adaptations of energy metabolism associated with increased levels of mitochondrial cholesterol in Niemann-Pick type C1-deficient cells","volume":"289","author":"BE Kennedy","year":"2014","journal-title":"J Biol Chem"},{"issue":"Pt 10","key":"ref61","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/brain\/awt224","article-title":"Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease","volume":"136","author":"H Mortiboys","year":"2013","journal-title":"Brain"},{"key":"ref62","article-title":"UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2G2019S carriers and in vivo","author":"H Mortiboys","year":"2015","journal-title":"Neurology"},{"issue":"12","key":"ref63","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0006-2952(00)00281-1","article-title":"Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment","volume":"59","author":"S Miksys","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0090-9556(25)08620-9","article-title":"Cytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes","volume":"20","author":"MR Britto","year":"1992","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ana.20051","article-title":"CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease","volume":"55","author":"A Elbaz","year":"2004","journal-title":"Ann Neurol"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ymgme.2008.02.005","article-title":"Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis","volume":"94","author":"E Elliot-Smith","year":"2008","journal-title":"Molecular Genetics and Metabolism"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pbb.2011.12.009","article-title":"Lack of efficacy of curcumin on neurodegeneration in the mouse model of Niemann-Pick C1","volume":"101","author":"IA Borbon","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.nu.01.070181.001231","article-title":"The role of nutrition in toxicology","volume":"1","author":"DV Parke","year":"1981","journal-title":"Annual Review of Nutrition"},{"issue":"3 Pt 2","key":"ref69","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1016\/0272-0590(84)90262-8","article-title":"Drug-nutrient interactions and their implications for safety evaluations","volume":"4","author":"MW Conner","year":"1984","journal-title":"Fundamental and Applied Toxicology"},{"issue":"12","key":"ref70","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children","volume":"349","author":"GL Kearns","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"ref71","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0026-895X(25)09889-X","article-title":"On the substrate specificity of cytochrome P450IIIA1","volume":"34","author":"MJ Namkung","year":"1988","journal-title":"Mol Pharmacol"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.ijo.0800756","article-title":"Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob\/ob mice","volume":"23","author":"AL Roe","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ddr.430110205","article-title":"General neuropharmacology of vinpocetine: A putative cerebral activator","volume":"11","author":"KL Keim","year":"1987","journal-title":"Drug Development Research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0152007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:27:14Z","timestamp":1748824034000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0152007"}},"subtitle":[],"editor":[{"given":"Hongyuan Rob","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":73,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0152007","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]}}}